Edgewise Therapeutics Inc...

NASDAQ: EWTX · Real-Time Price · USD
14.15
0.22 (1.58%)
At close: Aug 15, 2025, 3:59 PM
14.31
1.10%
After-hours: Aug 15, 2025, 05:00 PM EDT

Edgewise Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
41.67M 86.1M 21.99M 15.57M
Short-Term Investments
428.5M 232.3M 329.95M 265.22M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
262K 348K 5.3M 3.53M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
5.31M 8.6M n/a n/a
Total Current Assets
475.48M 327M 357M 283.77M
Property-Plant & Equipment
11.07M 12.69M 9.85M 912K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
11.33M 13.04M 15.15M 4.44M
Total Assets
486.82M 340.04M 367.1M 285.23M
Account Payables
5.58M 4.03M 6.11M 3.84M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
996K 980K 608K n/a
Other Current Liabilities
9.06M 5.09M 5.23M n/a
Total Current Liabilities
23.86M 16.77M 16.59M 10.52M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 329K
Total Long-Term Liabilities
3.74M 4.43M 3.8M 329K
Total Liabilities
27.6M 21.2M 20.39M 10.85M
Total Debt
4.74M 5.41M 4.41M n/a
Common Stock
9K 7K 6K 5K
Retained Earnings
-378.58M -244.76M -144.6M -76.96M
Comprehensive Income
420K 99K -1.35M -514K
Shareholders Equity
459.22M 318.83M 346.72M 274.38M
Total Investments
428.5M 232.3M 329.95M 265.22M